Hospital
Memorial Hospital
Memorial Hospital was paid $11.40M by Medicaid between Jan 2018 and Dec 2024, across 223 billing codes. Its largest line is 99283, emergency room visit (moderate) — 21% of everything it billed.
33Billing provider infoMEMORIAL HOSPITAL
FREMONT, OH 43420
FREMONT, OH 43420
33aNPI1851338149assigned 06/02/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$11.40M
24GClaims292,878
24DCodes billed223
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Ohio
Rank by total paid#71 of 101
Median peer was paid$22.32M
This provider vs. median0.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 18,317 | $741K | |
| 2019 | 22,003 | $785K | |
| 2020 | 19,138 | $841K | |
| 2021 | 18,975 | $825K | |
| 2022 | 18,716 | $880K | |
| 2023 | 109,447 | $4.11M | |
| 2024incomplete | 86,282 | $3.21M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 21% | 24,109 | 22,130 | $2.45M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 11% | 11,946 | 10,434 | $1.29M |
| 96361 | Intravenous infusion, hydration; each additional hour | 8.8% | 3,693 | 2,550 | $998K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.5% | 5,644 | 4,795 | $621K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 3.8% | 4,149 | 3,473 | $437K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.5% | 4,387 | 3,903 | $396K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3.2% | 5,459 | 1,586 | $369K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.8% | 1,386 | 1,132 | $317K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.7% | 1,438 | 1,203 | $313K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.4% | 5,121 | 3,733 | $274K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 2.3% | 3,925 | 1,270 | $263K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.2% | 1,448 | 1,355 | $245K |
211 more codes
| 99213 | Doctor's office visit, returning patient (routine) | 1.9% | 4,551 | $213K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.8% | 1,992 | $208K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.7% | 2,491 | $195K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.6% | 749 | $177K |
| 80053 | Comprehensive metabolic panel | 1.6% | 16,928 | $177K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1.5% | 1,154 | $166K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.3% | 1,778 | $146K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.3% | 747 | $145K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.2% | 622 | $132K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.1% | 1,162 | $126K |
| G0378 | Hospital observation service, per hour | <1% | 1,716 | $106K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 535 | $91K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 278 | $67K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 24,324 | $56K |
| 59025 | Fetal non-stress test | <1% | 350 | $55K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 587 | $54K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,470 | $51K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,092 | $39K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,713 | $38K |
| 36415 | Collection of venous blood by venipuncture | <1% | 20,008 | $38K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 338 | $31K |
| 76801 | <1% | 297 | $31K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,931 | $31K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,330 | $31K |
| 84439 | <1% | 2,192 | $31K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,004 | $29K |
| 64493 | <1% | 89 | $28K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,719 | $25K |
| 96367 | <1% | 511 | $25K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,624 | $25K |
| 80074 | <1% | 1,523 | $24K | |
| 94060 | <1% | 216 | $24K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 879 | $24K |
| 85027 | <1% | 2,411 | $23K | |
| 97161 | <1% | 518 | $23K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 8,170 | $23K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,027 | $22K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 505 | $21K |
| 80061 | Lipid panel | <1% | 1,783 | $20K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 152 | $19K |
| 97113 | <1% | 256 | $18K | |
| 74018 | <1% | 536 | $17K | |
| 87522 | Neg quan hep c or qual rna | <1% | 516 | $17K |
| 84702 | <1% | 922 | $17K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 342 | $17K |
| 76830 | Ultrasound, transvaginal | <1% | 490 | $16K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 113 | $16K |
| 97162 | <1% | 369 | $15K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 74 | $14K |
| 86780 | <1% | 667 | $14K | |
| 72100 | <1% | 440 | $14K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,327 | $14K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 879 | $14K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,082 | $13K |
| 82607 | <1% | 610 | $13K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 211 | $12K |
| 82728 | <1% | 696 | $12K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 236 | $12K |
| 76770 | <1% | 103 | $12K | |
| 64635 | <1% | 110 | $12K | |
| 94729 | <1% | 223 | $12K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 773 | $12K |
| 86850 | <1% | 581 | $11K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 557 | $11K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 16 | $10K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 78 | $9K |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 305 | $9K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 13 | $9K |
| 94726 | <1% | 163 | $9K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 68 | $9K |
| 73562 | <1% | 512 | $8K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 69 | $8K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 42 | $8K |
| 83655 | <1% | 351 | $8K | |
| 83540 | <1% | 741 | $8K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 137 | $7K |
| 86140 | <1% | 1,159 | $7K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 448 | $7K |
| 83735 | <1% | 5,537 | $7K | |
| 71250 | <1% | 124 | $7K | |
| 80076 | <1% | 952 | $7K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 364 | $6K |
| 86900 | <1% | 622 | $6K | |
| 73030 | <1% | 407 | $6K | |
| 0012A | <1% | 153 | $6K | |
| 73630 | <1% | 465 | $5K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 505 | $5K |
| 84484 | <1% | 4,298 | $5K | |
| 97166 | <1% | 76 | $5K | |
| 0011A | <1% | 152 | $5K | |
| 83550 | <1% | 637 | $5K | |
| 71045 | Radiologic examination, chest; single view | <1% | 3,320 | $5K |
| 82570 | <1% | 732 | $5K | |
| 73130 | <1% | 398 | $4K | |
| 73610 | <1% | 405 | $4K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 4,745 | $4K |
| 83970 | <1% | 150 | $4K | |
| 81001 | <1% | 1,140 | $4K | |
| 93017 | <1% | 64 | $4K | |
| 86901 | <1% | 622 | $4K | |
| 85610 | <1% | 3,932 | $4K | |
| 97010 | <1% | 103 | $4K | |
| 81003 | <1% | 10,066 | $4K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,972 | $4K |
| 73502 | <1% | 186 | $3K | |
| 85652 | <1% | 555 | $3K | |
| 81514 | <1% | 14 | $2K | |
| 82746 | <1% | 189 | $2K | |
| 93975 | <1% | 24 | $2K | |
| 73110 | <1% | 161 | $2K | |
| 85018 | <1% | 374 | $2K | |
| 82950 | <1% | 149 | $2K | |
| G0260 | Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography | <1% | 12 | $2K |
| 86787 | <1% | 52 | $2K | |
| 90715 | <1% | 121 | $2K | |
| 87077 | <1% | 795 | $1K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 642 | $1K |
| 87660 | <1% | 79 | $1K | |
| 84100 | <1% | 478 | $1K | |
| 92523 | <1% | 17 | $1K | |
| 86803 | <1% | 67 | $1K | |
| 84550 | <1% | 303 | $1K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,668 | $1K |
| 83690 | <1% | 2,510 | $1K | |
| 84146 | <1% | 70 | $1K | |
| 84153 | <1% | 92 | $1K | |
| 82043 | <1% | 201 | $1K | |
| 96376 | <1% | 1,084 | $1K | |
| 86762 | <1% | 61 | $1K | |
| 84156 | <1% | 350 | $1K | |
| 83880 | <1% | 1,103 | $1K | |
| 86038 | <1% | 38 | $879.91 | |
| 27096 | <1% | 20 | $876.67 | |
| 87186 | <1% | 442 | $870.58 | |
| 85730 | <1% | 1,286 | $821.98 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 3,440 | $753.95 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,185 | $750.70 |
| 82077 | <1% | 1,127 | $742.19 | |
| 83001 | <1% | 31 | $676.73 | |
| 64494 | <1% | 94 | $670.76 | |
| 87480 | <1% | 37 | $656.51 | |
| 81025 | <1% | 3,581 | $645.02 | |
| 82550 | <1% | 181 | $614.40 | |
| 87040 | <1% | 523 | $593.63 | |
| 82784 | <1% | 30 | $456.30 | |
| 85379 | <1% | 1,260 | $418.40 | |
| 82565 | <1% | 63 | $381.67 | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 17 | $362.34 |
| 80143 | <1% | 551 | $346.84 | |
| 0031A | <1% | 12 | $342.62 | |
| 87510 | <1% | 37 | $337.12 | |
| 36591 | <1% | 23 | $335.69 | |
| 73080 | <1% | 25 | $280.44 | |
| 83605 | <1% | 1,370 | $270.14 | |
| 87340 | <1% | 12 | $266.04 | |
| 94664 | <1% | 253 | $234.66 | |
| 83002 | <1% | 13 | $214.62 | |
| 84481 | <1% | 14 | $214.42 | |
| 73590 | <1% | 15 | $194.81 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 557 | $192.98 |
| 84403 | <1% | 14 | $183.22 | |
| 97163 | <1% | 14 | $164.09 | |
| 80179 | <1% | 520 | $163.05 | |
| 85014 | <1% | 57 | $136.72 | |
| 82140 | <1% | 31 | $132.19 | |
| 82803 | <1% | 262 | $130.77 | |
| 83615 | <1% | 41 | $118.56 | |
| 82248 | <1% | 17 | $108.78 | |
| 84703 | <1% | 29 | $80.38 | |
| 82010 | <1% | 23 | $65.70 | |
| 84145 | <1% | 138 | $65.32 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 77 | $46.16 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 40 | $43.84 |
| 84132 | <1% | 48 | $41.65 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 392 | $38.52 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,119 | $38.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 206 | $37.63 |
| 82272 | <1% | 16 | $31.96 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 767 | $25.93 |
| 82150 | <1% | 42 | $22.83 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 38 | $21.21 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 688 | $20.44 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 16 | $19.96 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 492 | $19.46 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 702 | $17.86 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 305 | $16.36 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 171 | $16.03 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 35 | $14.05 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 267 | $12.96 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,141 | $12.21 |
| 94760 | <1% | 237 | $10.02 | |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | <1% | 33 | $10.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 36 | $7.88 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 901 | $7.03 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 120 | $4.80 |
| 91301 | <1% | 322 | $3.15 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 98 | $2.52 |
| J2704 | Injection, propofol, 10 mg | <1% | 874 | $1.80 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 388 | $0.26 |
| 91303 | <1% | 12 | $0.10 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 315 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 17 | $0.00 |
| 51702 | 0% | 12 | $0.00 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 125 | $0.00 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 0% | 355 | $0.00 |
| A9270 | Non-covered item or service | 0% | 242 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 46 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 64 | $0.00 |
| 87807 | 0% | 28 | $0.00 | |
| 80320 | 0% | 12 | $0.00 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSHARP, KEVIN (VP REV CYCLE)
| Provider | Location | Paid |
|---|---|---|
| The Toledo Hospital | Toledo, OH | $151.22M |
| Emma L. Bixby Medical Center | Adrian, MI | $18.35M |
| Bay Park Community Hospital | Oregon, OH | $16.39M |
| Community Health Center of Branch County | Coldwater, MI | $11.80M |
| Defiance Hospital INC. | Defiance, OH | $11.55M |
| Fostoria Hospital Association | Fostoria, OH | $7.48M |
| Toledo Hospital | Toledo, OH | $2.38M |
| Herrick Memorial Hospital, INC. | Tecumseh, MI | $1.82M |
| Flower Hospital | Sylvania, OH | $368K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.